Joint Formulary & PAD

Exenatide - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :
Important
Exenatide is not a preferred treatment option. The preferred GLP-1 for WEEKLY injection is dulaglutide. Prescribing may continue on existing patients.

PAD Profile

ChemicalSubstance :
Exenatide
Indication :
Diabetes Mellitus
Group Name :
Keywords :
GLP-1 with insulin; diabetes guidelines
Brand Names Include :
Bydureon
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5

Other Indications

Below are listed other indications that Exenatide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.

Committee Recommendations (1)

Not a preferred treatment option.
See guidelines below and associated documentation for further information